A preliminary evaluation of internalized stigma and stigma resistance in inflammatory bowel disease
- PMID: 22689587
- PMCID: PMC8451966
- DOI: 10.1177/1359105312446768
A preliminary evaluation of internalized stigma and stigma resistance in inflammatory bowel disease
Abstract
Illness stigmatization among inflammatory bowel diseases (IBDs) is poorly understood. We aim to characterize internalized stigma and stigma resistance in IBD patients, and evaluate their relationships to outcomes. A total of 191 IBD patients reported internalized stigma, resistance, demographic and clinical information, and several outcomes: health-related quality of life (HRQOL), psychological distress, self-esteem, and self-efficacy. Overall 36% experienced internalized stigma and 88% moderate to high stigma resistance behaviors. Internalized stigma strongly related to poorer outcomes while resistance demonstrated a weaker, opposite effect. Internalized stigma and stigma resistance are important considerations for IBD outcomes. Interventions to reduce internalized stigma and leverage resistance are warranted.
Conflict of interest statement
References
-
- Brensnahan M and Zhuang J (2011) Exploration and validation of the dimensions of stigma. Journal of Health Psychology 16(3): 421–429. - PubMed
-
- Buseh AG and Stevens PE (2006) Constrained but not determined by stigma: Resistance by African American women living with HIV. Women Health 44(3): 1–18. - PubMed
-
- Casati J and Toner BB (2000) Psychosocial aspects of inflammatory bowel disease. Biomedecine & Pharmacotherapy 54(7): 388–393. - PubMed
-
- Casati J, Toner BB, De Rooy EC, Drossman DA and Maunder RG (2000) REVIEW: Concerns of patients with inflammatory bowel disease. Digestive Diseases and Sciences 45(1): 26–31. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
